DIE PHOSPHOGLUKOSE-ISOMERASE-EIN DIAGNOSTISCHES KRITERIUM DER PSORIASIS VULGARIS. = LA PHOSPHOGLUCO-ISOMERASE, UN CRITERE DIAGNOSTIQUE DU PSORIASIS.MEYER J; KLEEBERG U.1972; DERMATOL. MONATSSCHR.; DTSCH.; DA. 1972; VOL. 158; NO 9; PP. 620-625; BIBL. 16 REF.Serial Issue

Indikationen, Wirkung, Nutzen und Sinn einer palliativen Behandlung tumorkranker Menschen = Indications of palliative care in malignant tumorsKLEEBERG, U. R.Geburtshilfe und Frauenheilkunde. 1999, Vol 59, Num 5, pp M57-M60, issn 0016-5751Article

Die Rolle des Onkologen bei der psychologischen Betreuung seiner Patienten = Le rôle de l'oncologue dans les soins psychologiques accordés à ses patients = The role of the oncologist in the psychological care for his patientsKLEEBERG, U. R.Psychotherapie, Psychosomatik, medizinische Psychologie. 1986, Vol 36, Num 3-4, pp 130-135, issn 0173-7937Article

PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma: a pilot study = Polychimiothérapie par PALA, vindésine et cisplatine dans les mélanones malins avancés. Une étude piloteVOIGT, H; KLEEBERG, U. R.Cancer. 1984, Vol 53, Num 10, pp 2058-2062, issn 0008-543XArticle

Extrapolation vom Tierversuch auf Reaktionen beim Menschen = L'extrapolation de l'essai sur l'animal aux réactions chez l'homme = Extrapolation from animal experiments to reactions in manKLINGER, W; MÜLLER, D; KLEEBERG, U et al.Pharmazie. 1983, Vol 38, Num 9, pp 621-623, issn 0031-7144Article

CONGENITAL STOMATOCYTOSIS AND CHRONIC HAEMOLYTIC ANAEMIA = STOMATOCYTOSE CONGENITALE ET ANEMIE HEMOLYTIQUE CHRONIQUEBIENZLE U; NIETHAMMER D; KLEEBERG U et al.1975; SCAND. J. HAEMATOL.; DENM.; DA. 1975; VOL. 15; NO 5; PP. 339-346; BIBL. 1 P. 1/2Article

Time-dependent transcriptional induction of CYP1A1, CYP1A2 and CYP1B1 mRNAs by H⁺/K⁺-ATPase inhibitors and other xenobioticsKRUSEKOPF, S; ROOTS, I; HILDEBRANDT, A. G et al.Xenobiotica (London. Print). 2003, Vol 33, Num 2, pp 107-118, issn 0049-8254, 12 p.Article

Phase I study of pirarubicinMILLER, A. A; SCHEULEN, M. E; KLEEBERG, U. R et al.Journal of cancer research and clinical oncology. 1988, Vol 114, Num 1, pp 91-94, issn 0171-5216Article

The influence of essential phospholipids (EPL) on phase-I- and phase-II-reactions and on the glutathione status in the liver of aging ratsKLINGER, W; MÜLLER, D; KLEEBERG, U et al.Experimental pathology (1981). 1991, Vol 41, Num 3, pp 151-156, issn 0232-1513Article

Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer: a phase II study of the association of medical oncology of the German cancer society (AIO)WANDER, H.-E; NAGEL, G. A; BLOSSEY, H.-C et al.Cancer. 1986, Vol 58, Num 9, pp 1985-1989, issn 0008-543XArticle

An assessment of DTIC versus levamisole or placebo in the treatment of high risk stage I patients after surgical removal of a primary melanoma of the skin. A phase III adjuvant study. EORTC protocol 18761LEJEUNE, F. J; MACHER, E; KLEEBERG, U et al.European journal of cancer & clinical oncology. 1988, Vol 24, pp 81-90, issn 0277-5379, suppl. 2Article

Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapyVERGOTE, I; ROBERTSON, J. F. R; KLEEBERG, U et al.Breast cancer research and treatment. 2003, Vol 79, Num 2, pp 207-211, issn 0167-6806, 5 p.Article

Melanoma risk and residence in sunny areasAUTIER, P; DORE, J. F; GEFELLER, O et al.British journal of cancer. 1997, Vol 76, Num 11, pp 1521-1524, issn 0007-0920Article

A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancerKLEEBERG, U. R; DOWSETT, M; CARRION, R. P et al.Oncology. 1997, Vol 54, pp 19-22, issn 0030-2414, SUP2Conference Paper

The EORTC melanoma group exchange progam : evaluation of a multicenter monoclonal antibody studyCARREL, S; DORE, J.-F; RUITER, D. J et al.International journal of cancer. 1991, Vol 48, Num 6, pp 836-847, issn 0020-7136Article

The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines : a multicentre phase II trialAL-BATRAN, S.-E; BISCHOFF, J; KNUTH, A et al.British journal of cancer. 2006, Vol 94, Num 11, pp 1615-1620, issn 0007-0920, 6 p.Article

A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex®) with intramuscular formestane in postmenopausal women with advanced breast cancerVOROBIOF, D. A; KLEEBERG, U. R; PEREZ-CARRION, R et al.Annals of oncology. 1999, Vol 10, Num 10, pp 1219-1225, issn 0923-7534Article

Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patientsKÖLMEL, K. F; GRANGE, J. M; SHAFIR, R et al.European journal of cancer (1990). 2005, Vol 41, Num 1, pp 118-125, issn 0959-8049, 8 p.Article

High tPA-expression in primary melanoma of the limb correlates with good prognosisFERRIER, C. M; SUCIU, S; RUITER, D. J et al.British journal of cancer. 2000, Vol 83, Num 10, pp 1351-1359, issn 0007-0920Article

Treatment of metastatic colorectal carcinoma with a combination of fluorouracil and recombinant interferon alfa-2b : preliminary data of a phase II studyWEH, H. J; PLATZ, D; MÜLLER, P et al.Seminars in oncology. 1992, Vol 19, Num 2, pp 180-184, issn 0093-7754, SUP3Conference Paper

Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinomaWEH, H. J; PLATZ, D; HOFFMANN, R et al.European journal of cancer. Part A. 1992, Vol 28, Num 11, pp 1820-1823Article

Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alphaHEHLMANN, R; ANGER, B; WALTHER, F et al.Blut. 1988, Vol 56, Num 2, pp 87-91, issn 0006-5242Article

Randomized comparison of interferon-α with busulfant and hydroxyurea in chronic myelogenous leukemiaHEHLMANN, R; HEIMPEL, H; GEORGI, A et al.Blood. 1994, Vol 84, Num 12, pp 4064-4077, issn 0006-4971Article

Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia : prolongation of survival by hydroxyureaHEHLMANN, R; HEIMPEL, H; WUSSOW, P. V et al.Blood. 1993, Vol 82, Num 2, pp 398-407, issn 0006-4971Article